SynGap Missense Server

Table of SynGAP1 Isoform α2 (UniProt Q96PV0-1) Missense Variants.

c.dna Variant SGM Consensus Domain ClinVar gnomAD ESM1b AlphaMissense REVEL FoldX Rosetta Foldetta PremPS PROVEAN PolyPhen-2 HumDiv PolyPhen-2 HumVar FATHMM SIFT PAM Physical SASA Normalized B-factor backbone Normalized B-factor sidechain SynGAP Structural Annotation DOI
Clinical Status Review Subm. ID Allele count Allele freq. LLR score Prediction Pathogenicity Class Optimized Score Prediction Average ΔΔG Prediction StdDev ΔΔG Prediction ΔΔG Prediction ΔΔG Prediction Score Prediction pph2_prob Prediction pph2_prob Prediction Nervous System Score Prediction Prediction Status Conservation Sequences PAM250 PAM120 Hydropathy Δ MW Δ Average Δ Δ StdDev Δ StdDev Secondary Tertiary bonds Inside out GAP-Ras interface At membrane No effect MD Alert Verdict Description
c.2369C>AT790NSH3-binding motifConflicting 36-33442921-C-A694.28e-5-5.243Likely Benign0.276Likely BenignLikely Benign0.103Likely Benign-2.54Deleterious0.999Probably Damaging0.997Probably Damaging2.27Pathogenic0.02Affected3.64600-2.813.00
c.2900G>AR967QLikely BenignBenign/Likely benign 26-33443452-G-A311.92e-5-3.057Likely Benign0.080Likely BenignLikely Benign0.104Likely Benign-0.01Neutral0.994Probably Damaging0.626Possibly Damaging4.21Benign0.36Tolerated4.322111.0-28.06
c.1904A>GN635S
(3D Viewer)
GAPConflicting 46-33440956-A-G106.20e-6-9.002Likely Pathogenic0.101Likely BenignLikely Benign0.104Likely Benign0.80Ambiguous0.10.67Ambiguous0.74Ambiguous0.95Ambiguous-4.45Deleterious0.261Benign0.044Benign3.06Benign0.05Affected3.3734112.7-27.03196.030.90.10.0-0.30.2XUncertainIn the WT simulations, the carboxamide side chain of Asn635, located on the outer surface of an α helix (res. Glu617-Asn635), forms hydrogen bonds with Gln631 on the same α helix and with the hydroxyl side chain of Ser590 on an opposing α helix (res. Glu582-Met603).In the variant simulations, the side chain of Ser635 is shorter than asparagine and thus prefers to hydrogen bond with the carbonyl group of Gln631 on the same helix and, to a lesser extent, with Ser590 compared to Asn635 in the WT. Ser635 forms hydrogen bonds with the backbone atoms of the same helix, which may destabilize the helix, although this is not clearly evident in the simulations. The weakening of the hydrogen bond between Ser635 and Ser590 in the variant may also weaken the tertiary structure assembly between the helices.Additionally, Asn635 is at the GTPase interface. However, the implication of the residue swap on the complex formation with the GTPase cannot be investigated using solvent-only simulations.
c.3209G>AR1070KLikely BenignConflicting 2-5.093Likely Benign0.326Likely BenignLikely Benign0.104Likely Benign-1.42Neutral0.049Benign0.048Benign3.86Benign0.09Tolerated3.775320.6-28.01
c.3314G>AR1105QLikely BenignUncertain 26-33443866-G-A31.96e-6-3.666Likely Benign0.216Likely BenignLikely Benign0.104Likely Benign-1.21Neutral0.958Probably Damaging0.194Benign2.50Benign0.16Tolerated3.775111.0-28.06
c.3846G>CE1282DLikely BenignUncertain 16-33447894-G-C16.44e-7-3.879Likely Benign0.074Likely BenignLikely Benign0.104Likely Benign-1.26Neutral0.112Benign0.036Benign2.70Benign0.39Tolerated3.775320.0-14.03
c.3260C>TS1087FUncertain 1-3.843Likely Benign0.497AmbiguousLikely Benign0.105Likely Benign-2.75Deleterious0.990Probably Damaging0.796Possibly Damaging2.56Benign0.03Affected3.775-2-33.660.10
c.44C>TA15VLikely BenignUncertain 16-33420308-C-T16.49e-7-3.560Likely Benign0.161Likely BenignLikely Benign0.105Likely Benign0.20Neutral0.602Possibly Damaging0.015Benign4.19Benign0.00Affected4.321002.428.05
c.3424T>CS1142PLikely BenignLikely Benign 16-33444459-T-C16.20e-7-2.713Likely Benign0.222Likely BenignLikely Benign0.107Likely Benign-2.19Neutral0.918Possibly Damaging0.761Possibly Damaging2.64Benign0.00Affected4.324-11-0.810.04
c.2573G>AS858NLikely BenignUncertain 16-33443125-G-A21.24e-6-4.311Likely Benign0.121Likely BenignLikely Benign0.107Likely Benign-0.67Neutral0.448Benign0.846Possibly Damaging4.13Benign0.02Affected3.77511-2.727.03
c.2768T>AI923NLikely BenignUncertain 1-0.733Likely Benign0.712Likely PathogenicLikely Benign0.108Likely Benign-1.16Neutral0.991Probably Damaging0.793Possibly Damaging2.70Benign0.13Tolerated3.775-2-3-8.00.94
c.3172G>AG1058SLikely BenignConflicting 36-33443724-G-A1147.08e-5-5.178Likely Benign0.081Likely BenignLikely Benign0.108Likely Benign0.26Neutral0.001Benign0.001Benign5.38Benign0.04Affected3.77510-0.430.03
c.269T>AV90ELikely BenignUncertain 1-4.079Likely Benign0.703Likely PathogenicLikely Benign0.108Likely Benign-0.38Neutral0.001Benign0.000Benign4.00Benign0.00Affected4.321-2-2-7.729.98
c.416G>AS139NLikely BenignUncertain 16-33432713-G-A32.22e-6-4.584Likely Benign0.688Likely PathogenicLikely Benign0.109Likely Benign-0.75Neutral0.149Benign0.047Benign4.14Benign0.24Tolerated3.61511-2.727.03
c.2924C>GT975SLikely BenignUncertain 1-2.743Likely Benign0.068Likely BenignLikely Benign0.109Likely Benign-0.57Neutral0.059Benign0.061Benign4.16Benign0.20Tolerated11-0.1-14.03
c.3026A>CE1009ALikely PathogenicUncertain 1-3.118Likely Benign0.679Likely PathogenicLikely Benign0.109Likely Benign-3.06Deleterious0.980Probably Damaging0.630Possibly Damaging2.39Pathogenic0.01Affected3.7750-15.3-58.04
c.3056G>TR1019LLikely PathogenicUncertain 16-33443608-G-T21.24e-6-5.194Likely Benign0.752Likely PathogenicLikely Benign0.110Likely Benign-3.57Deleterious0.800Possibly Damaging0.573Possibly Damaging2.40Pathogenic0.01Affected3.775-2-38.3-43.03
c.37A>GI13VLikely BenignUncertain 1-2.497Likely Benign0.105Likely BenignLikely Benign0.110Likely Benign0.01Neutral0.000Benign0.000Benign4.25Benign0.00Affected43-0.3-14.03
c.2623G>AA875TLikely BenignUncertain 16-33443175-G-A16.20e-7-3.793Likely Benign0.179Likely BenignLikely Benign0.110Likely Benign-1.56Neutral0.972Probably Damaging0.864Possibly Damaging2.72Benign0.26Tolerated3.77501-2.530.03
c.505G>AD169NUncertain 1-10.713Likely Pathogenic0.761Likely PathogenicLikely Benign0.110Likely Benign-2.04Neutral0.079Benign0.052Benign4.07Benign0.01Affected3.744210.0-0.98
c.272A>GE91GLikely BenignLikely Benign 1-3.226Likely Benign0.783Likely PathogenicLikely Benign0.110Likely Benign-2.18Neutral0.947Possibly Damaging0.727Possibly Damaging3.86Benign0.00Affected4.3210-23.1-72.06
c.2608C>GL870VLikely BenignUncertain 1-4.123Likely Benign0.300Likely BenignLikely Benign0.111Likely Benign-1.19Neutral0.997Probably Damaging0.992Probably Damaging2.64Benign0.12Tolerated3.883210.4-14.03
c.2047A>GI683V
(3D Viewer)
Likely BenignGAPUncertain 16-33441306-A-G21.24e-6-7.588In-Between0.138Likely BenignLikely Benign0.112Likely Benign0.90Ambiguous0.00.60Ambiguous0.75Ambiguous0.76Ambiguous-0.78Neutral0.538Possibly Damaging0.080Benign3.35Benign0.14Tolerated3.421743-0.3-14.03215.629.10.00.0-0.70.1XPotentially BenignThe sec-butyl side chain of Ile683, located in an entangled α-α loop connecting the two α-helices (res. Ser641-Glu666 and res. Leu685-Val699), is sterically packed against His453 and Glu688. In the variant simulations, the iso-propyl side chain of Val683 has similar size and physicochemical properties as Ile630 in the WT, and thus, it is able to maintain similar interactions in the inter-helix space. Consequently, no negative structural effects are observed during the simulations due to the residue swap.
c.2724G>CQ908HLikely BenignConflicting 46-33443276-G-C16.20e-7-4.658Likely Benign0.311Likely BenignLikely Benign0.112Likely Benign-0.74Neutral0.996Probably Damaging0.995Probably Damaging2.58Benign0.05Affected3.775300.39.01
c.3002T>CL1001PLikely BenignUncertain 1-3.071Likely Benign0.209Likely BenignLikely Benign0.113Likely Benign-1.02Neutral0.966Probably Damaging0.690Possibly Damaging2.65Benign0.00Affected4.324-3-3-5.4-16.04
c.2459A>GY820CLikely PathogenicUncertain 1-8.797Likely Pathogenic0.744Likely PathogenicLikely Benign0.113Likely Benign-3.16Deleterious1.000Probably Damaging0.983Probably Damaging2.68Benign0.06Tolerated3.7750-23.8-60.04
c.2719A>TS907CLikely BenignLikely Benign 1-6.685Likely Benign0.298Likely BenignLikely Benign0.113Likely Benign-2.34Neutral0.999Probably Damaging0.988Probably Damaging2.60Benign0.02Affected3.7750-13.316.06
c.335G>CG112ALikely BenignUncertain 16-33432200-G-C159.30e-6-2.456Likely Benign0.119Likely BenignLikely Benign0.114Likely Benign-2.34Neutral0.231Benign0.054Benign4.07Benign0.00Affected3.615102.214.03
c.3250C>GP1084ALikely BenignUncertain 1-3.928Likely Benign0.066Likely BenignLikely Benign0.114Likely Benign-2.54Deleterious0.649Possibly Damaging0.157Benign4.05Benign0.35Tolerated3.775-113.4-26.04
c.3943T>CW1315RLikely BenignUncertain 10.205Likely Benign0.660Likely PathogenicLikely Benign0.114Likely Benign1.31Neutral0.000Benign0.001Benign4.37Benign0.91Tolerated3.7752-3-3.6-30.03
c.2735C>AT912NLikely BenignUncertain 1-4.260Likely Benign0.190Likely BenignLikely Benign0.116Likely Benign-1.15Neutral0.999Probably Damaging0.977Probably Damaging3.96Benign0.00Affected3.77500-2.813.00
c.3308G>AR1103HLikely BenignBenign/Likely benign 36-33443860-G-A312.03e-5-3.622Likely Benign0.156Likely BenignLikely Benign0.116Likely Benign-1.97Neutral0.996Probably Damaging0.733Possibly Damaging2.49Pathogenic0.01Affected3.775201.3-19.05
c.1345A>GS449G
(3D Viewer)
Likely BenignGAPUncertain 16-33438250-A-G31.86e-6-5.936Likely Benign0.071Likely BenignLikely Benign0.116Likely Benign0.47Likely Benign0.00.55Ambiguous0.51Ambiguous0.85Ambiguous-2.32Neutral0.948Possibly Damaging0.124Benign3.35Benign0.13Tolerated3.3732010.4-30.03
c.899C>TS300F
(3D Viewer)
Likely PathogenicC2Uncertain 1-10.222Likely Pathogenic0.353AmbiguousLikely Benign0.117Likely Benign-0.29Likely Benign0.40.16Likely Benign-0.07Likely Benign0.04Likely Benign-2.66Deleterious0.975Probably Damaging0.596Possibly Damaging1.52Pathogenic0.01Affected3.4719-3-23.660.10233.6-67.6-0.10.00.40.2XXPotentially PathogenicThe hydroxyl group of the Ser300 side chain, located in a β hairpin loop linking two anti-parallel β sheet strands (res. Met289-Pro298, res. Thr305-Asn315), hydrogen bonds with the guanidinium group of Arg299 and the backbone amide group and side chain of Ser302. Thus, in the WT simulations, it contributes to the β hairpin stability. In the variant simulations, the phenol ring of Phe300 cannot form any side chain-related hydrogen bonds, and Arg299 is moved away from its central hairpin loop position.β hairpins are potential nucleation sites during the initial stages of protein folding, so even minor changes in them could be significant. Due to its location near the membrane surface, the residue swap could also affect the C2 loop dynamics and SynGAP-membrane association. However, this is beyond the scope of the solvent-only simulations to unravel.
c.3824G>TR1275LLikely Benign 16-33447872-G-T16.45e-7-6.052Likely Benign0.446AmbiguousLikely Benign0.117Likely Benign-4.04Deleterious0.800Possibly Damaging0.277Benign2.55Benign0.01Affected3.775-3-28.3-43.03
c.3977C>TP1326LLikely BenignUncertain 1-5.541Likely Benign0.115Likely BenignLikely Benign0.117Likely Benign-1.06Neutral0.999Probably Damaging0.994Probably Damaging3.62Benign0.00Affected3.775-3-35.416.04
c.379C>TR127WUncertain 1-4.776Likely Benign0.806Likely PathogenicAmbiguous0.118Likely Benign-2.98Deleterious0.989Probably Damaging0.420Benign3.88Benign0.00Affected2-33.630.03
c.1222A>GT408AC2Uncertain 1-8.304Likely Pathogenic0.114Likely BenignLikely Benign0.118Likely Benign0.37Likely Benign0.6-0.06Likely Benign0.16Likely Benign0.72Ambiguous-3.07Deleterious0.540Possibly Damaging0.131Benign4.16Benign0.14Tolerated102.5-30.03
c.431C>TT144MLikely PathogenicUncertain 26-33432728-C-T21.30e-6-11.228Likely Pathogenic0.922Likely PathogenicAmbiguous0.118Likely Benign-3.16Deleterious0.913Possibly Damaging0.333Benign3.73Benign0.00Affected3.615-1-12.630.09
c.3304G>CA1102PLikely BenignUncertain 1-5.120Likely Benign0.077Likely BenignLikely Benign0.118Likely Benign-0.97Neutral0.000Benign0.002Benign2.26Pathogenic0.13Tolerated3.775-11-3.426.04
c.2684G>AS895NLikely BenignUncertain 1-6.399Likely Benign0.604Likely PathogenicLikely Benign0.118Likely Benign-0.85Neutral0.991Probably Damaging0.988Probably Damaging2.64Benign0.30Tolerated4.32411-2.727.03
c.2753C>TA918VLikely BenignUncertain 36-33443305-C-T21.24e-6-3.684Likely Benign0.112Likely BenignLikely Benign0.119Likely Benign-1.61Neutral0.980Probably Damaging0.782Possibly Damaging2.61Benign0.03Affected4.324002.428.05
c.2521G>AV841MUncertain 16-33443073-G-A31.86e-6-7.000In-Between0.651Likely PathogenicLikely Benign0.119Likely Benign-0.74Neutral0.999Probably Damaging0.998Probably Damaging2.54Benign0.02Affected3.77512-2.332.06
c.266C>TP89LUncertain 2-6.775Likely Benign0.982Likely PathogenicLikely Pathogenic0.119Likely Benign-3.29Deleterious0.889Possibly Damaging0.058Benign3.73Benign0.00Affected4.321-3-35.416.04
c.373C>TP125SLikely BenignUncertain 1-3.769Likely Benign0.238Likely BenignLikely Benign0.121Likely Benign-3.57Deleterious0.580Possibly Damaging0.140Benign2.86Benign0.02Affected3.6151-10.8-10.04
c.3056G>AR1019HLikely BenignConflicting 26-33443608-G-A674.15e-5-4.610Likely Benign0.258Likely BenignLikely Benign0.122Likely Benign-1.95Neutral0.995Probably Damaging0.845Possibly Damaging2.39Pathogenic0.01Affected3.775201.3-19.05
c.2900G>TR967LLikely BenignUncertain 16-33443452-G-T16.20e-7-3.496Likely Benign0.164Likely BenignLikely Benign0.123Likely Benign-0.99Neutral0.959Probably Damaging0.586Possibly Damaging4.15Benign0.75Tolerated4.322-2-38.3-43.03
c.3237C>AS1079RLikely BenignUncertain 16-33443789-C-A42.51e-6-4.579Likely Benign0.955Likely PathogenicAmbiguous0.123Likely Benign-1.81Neutral0.177Benign0.075Benign3.86Benign0.00Affected3.7750-1-3.769.11
c.3932T>CL1311PLikely BenignLikely Benign 16-33451806-T-C16.21e-7-1.831Likely Benign0.079Likely BenignLikely Benign0.123Likely Benign-0.52Neutral0.579Possibly Damaging0.335Benign2.72Benign0.18Tolerated3.775-3-3-5.4-16.04
c.3237C>GS1079RLikely BenignBenign 1-4.579Likely Benign0.955Likely PathogenicAmbiguous0.124Likely Benign-1.81Neutral0.177Benign0.075Benign3.86Benign0.00Affected3.7750-1-3.769.11
c.2353C>TR785CLikely PathogenicSH3-binding motifUncertain 16-33442905-C-T291.80e-5-5.887Likely Benign0.662Likely PathogenicLikely Benign0.126Likely Benign-5.06Deleterious0.144Benign0.046Benign2.22Pathogenic0.00Affected3.646-4-37.0-53.05
c.4000A>GN1334DUncertain 16-33451874-A-G-4.584Likely Benign0.674Likely PathogenicLikely Benign0.126Likely Benign-3.06Deleterious0.886Possibly Damaging0.522Possibly Damaging3.55Benign0.00Affected3.775120.00.98
c.2015C>TT672M
(3D Viewer)
GAPConflicting 26-33441274-C-T191.18e-5-9.472Likely Pathogenic0.174Likely BenignLikely Benign0.127Likely Benign0.31Likely Benign0.41.52Ambiguous0.92Ambiguous0.41Likely Benign-4.34Deleterious0.993Probably Damaging0.520Possibly Damaging3.39Benign0.00Affected3.4025-1-12.630.09231.9-52.91.10.10.50.0XXPotentially PathogenicThe hydroxyl group of Thr672, located in an entangled α-α loop connecting the two α-helices (res. Ser641-Glu666 and res. Leu685-Val699), is involved in a highly coordinated hydrogen-bonding network between residues from two α-helices (res. Ser641-Glu666 and res. Arg563-Glu578) and from the α-α loop itself, such as Lys566, Glu666, and Asn669. Met672 can only form a hydrogen bond with the amino group of the Lys566 side chain via its backbone carbonyl group. Nevertheless, the Lys566-Glu666 salt bridge forms intermittently. This is possible because Asn669 keeps the carboxylate group of Glu666 in the vicinity through hydrogen bonding, and the hydrophobic side chain of Met stays mostly rotated away from the salt bridge. Consequently, no drastic disruption of the hydrogen-bond network that keeps the loop close to the helices occurs in the variant simulations.
c.3956C>GA1319GLikely BenignUncertain 26-33451830-C-G-3.927Likely Benign0.084Likely BenignLikely Benign0.128Likely Benign-0.74Neutral0.819Possibly Damaging0.581Possibly Damaging4.07Benign0.06Tolerated3.77510-2.2-14.03
c.3022G>AD1008NLikely BenignLikely Benign 16-33443574-G-A31.86e-6-4.045Likely Benign0.714Likely PathogenicLikely Benign0.128Likely Benign-2.15Neutral0.999Probably Damaging0.997Probably Damaging2.75Benign0.01Affected3.775210.0-0.98
c.2354G>AR785HSH3-binding motifUncertain 26-33442906-G-A42.50e-6-4.782Likely Benign0.388AmbiguousLikely Benign0.129Likely Benign-2.61Deleterious0.999Probably Damaging0.947Probably Damaging2.25Pathogenic0.01Affected3.646201.3-19.05
c.3290C>TP1097LLikely BenignBenign 1-4.410Likely Benign0.145Likely BenignLikely Benign0.131Likely Benign-2.07Neutral0.611Possibly Damaging0.198Benign2.64Benign0.05Affected3.775-3-35.416.04
c.558G>CL186FLikely PathogenicUncertain 1-11.861Likely Pathogenic0.993Likely PathogenicLikely Pathogenic0.132Likely Benign-3.03Deleterious0.009Benign0.012Benign3.50Benign0.00Affected20-1.034.02
c.1004G>AR335H
(3D Viewer)
Likely PathogenicC2Uncertain 16-33437909-G-A21.24e-6-12.521Likely Pathogenic0.831Likely PathogenicAmbiguous0.132Likely Benign0.58Ambiguous0.10.22Likely Benign0.40Likely Benign0.72Ambiguous-3.02Deleterious1.000Probably Damaging0.998Probably Damaging1.70Pathogenic0.03Affected3.3822201.3-19.05242.482.1-2.40.6-0.10.1UncertainThe guanidinium group of Arg335, located in a β hairpin loop linking two anti-parallel β sheet strands (res. Ala322-Asp330, res. Gly341-Pro349), faces the post-synaptic inner membrane surface. In the WT simulations, the Arg335 side chain dynamically forms salt bridges with the carboxylate groups of Asp322, Asp338, and Asp616. In contrast, the imidazole ring of His335, which is not double protonated and thus not positively charged in the variant simulations, continues to move dynamically without forming any lasting or strong interactions. Importantly, the positively charged arginine residues of the C2 domain are ideal membrane anchors for ensuring SynGAP-membrane association. However, this phenomenon cannot be addressed using solvent-only simulations.
c.2101C>TP701S
(3D Viewer)
Likely BenignGAPUncertain 16-33441360-C-T31.86e-6-4.375Likely Benign0.221Likely BenignLikely Benign0.132Likely Benign1.33Ambiguous0.00.12Likely Benign0.73Ambiguous-0.36Likely Benign0.78Neutral0.044Benign0.025Benign3.48Benign1.00Tolerated3.4710-110.8-10.0410.1016/j.ajhg.2020.11.011
c.3977C>GP1326RLikely BenignUncertain 1-5.097Likely Benign0.240Likely BenignLikely Benign0.133Likely Benign-0.82Neutral0.999Probably Damaging0.994Probably Damaging3.62Benign0.00Affected3.7750-2-2.959.07
c.3313C>TR1105WUncertain 16-33443865-C-T63.93e-6-6.911Likely Benign0.488AmbiguousLikely Benign0.133Likely Benign-4.34Deleterious0.999Probably Damaging0.696Possibly Damaging2.42Pathogenic0.02Affected3.775-323.630.03
c.223G>AE75KLikely BenignBenign/Likely benign 2-4.020Likely Benign0.358AmbiguousLikely Benign0.134Likely Benign-1.12Neutral0.748Possibly Damaging0.017Benign4.07Benign0.00Affected01-0.4-0.94
c.3223C>AQ1075KLikely BenignUncertain 1-5.135Likely Benign0.728Likely PathogenicLikely Benign0.134Likely Benign-0.67Neutral0.963Probably Damaging0.959Probably Damaging2.75Benign1.00Tolerated3.77511-0.40.04
c.3251C>AP1084HLikely BenignUncertain 16-33443803-C-A16.31e-7-4.125Likely Benign0.323Likely BenignLikely Benign0.134Likely Benign-3.16Deleterious0.997Probably Damaging0.840Possibly Damaging3.96Benign0.00Affected3.775-20-1.640.02
c.2369C>GT790SLikely BenignSH3-binding motifUncertain 1-3.914Likely Benign0.123Likely BenignLikely Benign0.134Likely Benign-1.83Neutral0.997Probably Damaging0.989Probably Damaging2.39Pathogenic0.33Tolerated3.64611-0.1-14.03
c.2962C>TL988FLikely BenignUncertain 16-33443514-C-T16.20e-7-4.368Likely Benign0.356AmbiguousLikely Benign0.135Likely Benign-1.70Neutral0.977Probably Damaging0.900Possibly Damaging2.69Benign0.00Affected4.32220-1.034.02
c.2818G>AG940SLikely BenignUncertain 16-33443370-G-A16.20e-7-5.451Likely Benign0.084Likely BenignLikely Benign0.135Likely Benign0.45Neutral0.409Benign0.253Benign2.77Benign0.44Tolerated3.77510-0.430.03
c.515G>AR172QUncertain 16-33435157-G-A31.86e-6-7.245In-Between0.465AmbiguousLikely Benign0.135Likely Benign-1.72Neutral0.804Possibly Damaging0.091Benign4.04Benign0.04Affected3.615111.0-28.06
c.2948G>AS983NLikely Benign 16-33443500-G-A63.72e-6-5.604Likely Benign0.909Likely PathogenicAmbiguous0.136Likely Benign-1.78Neutral0.991Probably Damaging0.988Probably Damaging2.04Pathogenic0.00Affected4.32111-2.727.03
c.2300T>CI767TLikely BenignUncertain 1-3.749Likely Benign0.252Likely BenignLikely Benign0.138Likely Benign-0.78Neutral0.625Possibly Damaging0.249Benign4.12Benign0.46Tolerated3.6460-1-5.2-12.05
c.2443C>AR815SSH3-binding motifBenign 1-7.324In-Between0.950Likely PathogenicAmbiguous0.138Likely Benign-1.86Neutral0.999Probably Damaging0.997Probably Damaging2.67Benign0.02Affected0-13.7-69.11
c.3977C>AP1326QLikely BenignUncertain 16-33451851-C-A16.40e-7-5.422Likely Benign0.128Likely BenignLikely Benign0.138Likely Benign-0.86Neutral0.999Probably Damaging0.994Probably Damaging3.62Benign0.00Affected3.775-10-1.931.01
c.2909A>GE970GLikely BenignBenign 1-0.167Likely Benign0.139Likely BenignLikely Benign0.139Likely Benign-0.93Neutral0.144Benign0.058Benign4.09Benign0.10Tolerated4.3220-23.1-72.06
c.1964T>AL655Q
(3D Viewer)
Likely BenignGAPUncertain 1-5.278Likely Benign0.144Likely BenignLikely Benign0.139Likely Benign-0.01Likely Benign0.00.69Ambiguous0.34Likely Benign-0.15Likely Benign0.61Neutral0.955Possibly Damaging0.602Possibly Damaging3.59Benign0.65Tolerated3.3924-2-2-7.314.97229.9-8.60.00.00.40.0XPotentially BenignThe iso-butyl side chain of Leu655, located on the surface of an α helix (res. Ser641-Glu666), is not involved in any interactions in the WT simulations. In the variant simulations, the carboxamide side chain of Gln655 dynamically interacts with neighboring residues (e.g., Glu651, Glu656, Arg544) on the protein surface, with no negative structural effects.
c.250C>GR84GUncertain 1-6.627Likely Benign0.989Likely PathogenicLikely Pathogenic0.139Likely Benign-2.64Deleterious0.962Probably Damaging0.726Possibly Damaging3.68Benign0.00Affected4.321-3-24.1-99.14
c.3307C>TR1103CUncertain 16-33443859-C-T63.92e-6-2.440Likely Benign0.246Likely BenignLikely Benign0.140Likely Benign-3.01Deleterious0.996Probably Damaging0.787Possibly Damaging2.41Pathogenic0.01Affected3.775-3-47.0-53.05
c.113C>TP38LLikely BenignConflicting 46-33423522-C-T84.96e-6-2.469Likely Benign0.197Likely BenignLikely Benign0.141Likely Benign-2.56Deleterious0.983Probably Damaging0.931Probably Damaging4.02Benign0.00Affected4.321-3-35.416.04
c.2812G>AG938RLikely BenignUncertain 1-5.271Likely Benign0.732Likely PathogenicLikely Benign0.141Likely Benign-1.11Neutral0.999Probably Damaging0.985Probably Damaging2.74Benign0.36Tolerated3.775-3-2-4.199.14
c.3009C>GS1003RUncertain 1-5.113Likely Benign0.991Likely PathogenicLikely Pathogenic0.141Likely Benign-1.88Neutral0.999Probably Damaging0.996Probably Damaging2.48Pathogenic0.00Affected3.7750-1-3.769.11
c.453C>AD151ELikely BenignUncertain 1-5.662Likely Benign0.886Likely PathogenicAmbiguous0.142Likely Benign-2.02Neutral0.984Probably Damaging0.967Probably Damaging3.99Benign0.11Tolerated3.615320.014.03
c.3980C>TP1327LLikely BenignUncertain 16-33451854-C-T21.28e-6-5.264Likely Benign0.242Likely BenignLikely Benign0.142Likely Benign-1.24Neutral0.994Probably Damaging0.908Possibly Damaging4.12Benign0.10Tolerated3.775-3-35.416.04
c.2113A>CK705Q
(3D Viewer)
Likely BenignGAPUncertain 16-33441372-A-C16.20e-7-5.787Likely Benign0.436AmbiguousLikely Benign0.142Likely Benign-0.10Likely Benign0.00.33Likely Benign0.12Likely Benign-0.02Likely Benign-0.24Neutral0.997Probably Damaging0.969Probably Damaging3.42Benign0.78Tolerated3.4710110.4-0.04
c.2750C>GP917RLikely BenignUncertain 16-33443302-C-G53.10e-6-4.475Likely Benign0.363AmbiguousLikely Benign0.142Likely Benign-1.70Neutral0.642Possibly Damaging0.316Benign2.68Benign0.00Affected3.775-20-2.959.07
c.2458T>AY820NUncertain 1-9.032Likely Pathogenic0.842Likely PathogenicAmbiguous0.143Likely Benign-1.53Neutral0.999Probably Damaging0.977Probably Damaging2.74Benign0.20Tolerated-2-2-2.2-49.07
c.2860C>TP954SLikely BenignLikely Benign 16-33443412-C-T16.20e-7-3.525Likely Benign0.062Likely BenignLikely Benign0.143Likely Benign-0.25Neutral0.954Possibly Damaging0.812Possibly Damaging2.87Benign1.00Tolerated3.7751-10.8-10.04
c.1888A>GI630V
(3D Viewer)
GAPBenign/Likely benign 46-33440940-A-G593.66e-5-7.264In-Between0.145Likely BenignLikely Benign0.143Likely Benign1.33Ambiguous0.00.94Ambiguous1.14Ambiguous0.64Ambiguous-0.38Neutral0.018Benign0.011Benign-1.37Pathogenic0.35Tolerated3.373443-0.3-14.03235.026.2-0.10.0-0.30.1XPotentially BenignThe sec-butyl side chain of Ile630, located in an α helix (res. Glu617-Asn635), packs with hydrophobic residues (e.g., Phe594, Leu633, Ile626, Ile602) in the hydrophobic inter-helix space between two α helices (res. Glu617-Asn635 and res. Glu582-Met603).In the variant simulations, the iso-propyl side chain of Val630, which shares a similar size and physicochemical properties with Ile630 in the WT, maintains similar interactions in the inter-helix space. Although no negative structural effects are observed during the simulations, the implications of the residue swap on the complex formation with the GTPase, due to its location, cannot be investigated using solvent-only simulations.
c.3640C>TR1214WLikely PathogenicCoiled-coilUncertain 16-33446632-C-T21.24e-6-8.799Likely Pathogenic0.710Likely PathogenicLikely Benign0.143Likely Benign-4.95Deleterious1.000Probably Damaging0.983Probably Damaging2.45Pathogenic0.00Affected3.7752-33.630.03
c.913A>GT305A
(3D Viewer)
Likely BenignC2Conflicting 26-33437818-A-G138.05e-6-4.307Likely Benign0.078Likely BenignLikely Benign0.144Likely Benign1.30Ambiguous0.61.55Ambiguous1.43Ambiguous0.77Ambiguous-2.10Neutral0.939Possibly Damaging0.645Possibly Damaging1.76Pathogenic0.12Tolerated3.4020102.5-30.03177.943.5-0.20.10.40.0UncertainThe hydroxyl group of Thr305, located at the beginning of an anti-parallel β strand (res. Thr305-Asn315), hydrogen bonds with the carboxylate groups of Glu270 and Asp304 in the anti-parallel β strand and the adjacent β hairpin loop, respectively. In the variant simulations, the methyl group of the Ala305 side chain cannot hydrogen bond with either of the acidic residues, which could weaken the integrity of the tertiary structure and the β hairpin loop. Indeed, the guanidinium group of Arg299 does not acquire its central hairpin loop position due to the residue swap.β hairpins are potential nucleation sites during the initial stages of protein folding, so even minor changes in them could be significant. Due to its location near the membrane surface, the residue swap could also affect the C2 loop dynamics and SynGAP-membrane association. However, this is beyond the scope of the solvent-only simulations to unravel.
c.1973G>AG658D
(3D Viewer)
GAPUncertain 16-33441232-G-A31.86e-6-7.786In-Between0.442AmbiguousLikely Benign0.144Likely Benign-0.40Likely Benign0.1-0.59Ambiguous-0.50Ambiguous0.46Likely Benign-2.64Deleterious0.008Benign0.005Benign3.53Benign0.38Tolerated3.39241-1-3.158.04219.8-84.30.00.00.20.1XPotentially PathogenicGly658, located on the outer surface of an α helix (res. Ser641-Glu666), weakens the helix integrity at that spot, which is necessary for the kink in the middle of the long helix. In the variant simulations, the carboxylic acid side chain of Asp658 is on the surface of the α helix and is not involved in any interactions. However, aspartate is not as effective a breaker of the secondary structure element as glycine, which may lead to misfolding.
c.3238G>AA1080TLikely BenignConflicting 26-33443790-G-A171.06e-5-3.928Likely Benign0.133Likely BenignLikely Benign0.144Likely Benign-0.19Neutral0.253Benign0.042Benign4.10Benign0.60Tolerated3.77510-2.530.03
c.2582C>TS861LLikely BenignUncertain 16-33443134-C-T21.24e-6-4.966Likely Benign0.219Likely BenignLikely Benign0.144Likely Benign-2.10Neutral0.904Possibly Damaging0.355Benign3.93Benign0.07Tolerated4.323-3-24.626.08
c.3323G>TS1108IUncertain 16-33443875-G-T-3.666Likely Benign0.292Likely BenignLikely Benign0.145Likely Benign-3.73Deleterious0.971Probably Damaging0.604Possibly Damaging2.44Pathogenic0.10Tolerated3.775-2-15.326.08
c.3196C>TP1066SLikely BenignLikely Pathogenic 1-4.746Likely Benign0.070Likely BenignLikely Benign0.145Likely Benign-2.47Neutral0.972Probably Damaging0.850Possibly Damaging2.74Benign0.00Affected4.3221-10.8-10.04
c.59C>GP20RLikely BenignUncertain 1-3.548Likely Benign0.434AmbiguousLikely Benign0.146Likely Benign-0.15Neutral0.972Probably Damaging0.804Possibly Damaging4.33Benign0.00Affected4.3210-2-2.959.07
c.2443C>GR815GSH3-binding motifUncertain 1-7.983In-Between0.854Likely PathogenicAmbiguous0.146Likely Benign-3.22Deleterious0.999Probably Damaging0.997Probably Damaging2.62Benign0.02Affected4.324-3-24.1-99.14
c.43G>CA15PLikely BenignUncertain 1-3.436Likely Benign0.097Likely BenignLikely Benign0.146Likely Benign-0.23Neutral0.880Possibly Damaging0.123Benign4.09Benign0.00Affected1-1-3.426.04
c.3974C>TP1325LLikely BenignUncertain 16-33451848-C-T-5.256Likely Benign0.085Likely BenignLikely Benign0.146Likely Benign-1.05Neutral0.000Benign0.000Benign4.05Benign0.00Affected4.321-3-35.416.04
c.1957C>GL653VLikely BenignGAPUncertain 1-7.050In-Between0.301Likely BenignLikely Benign0.146Likely Benign3.28Destabilizing0.32.18Destabilizing2.73Destabilizing1.32Destabilizing-2.25Neutral0.227Benign0.039Benign3.28Benign0.08Tolerated210.4-14.03
c.2249G>AG750EUncertain 1-2.618Likely Benign0.413AmbiguousLikely Benign0.146Likely Benign-2.27Neutral1.000Probably Damaging0.982Probably Damaging2.49Pathogenic0.01Affected3.9950-2-3.172.06
c.1260T>GF420L
(3D Viewer)
Likely PathogenicGAPUncertain 1-8.432Likely Pathogenic0.998Likely PathogenicLikely Pathogenic0.146Likely Benign1.76Ambiguous0.01.41Ambiguous1.59Ambiguous1.04Destabilizing-5.39Deleterious0.009Benign0.005Benign4.22Benign0.39Tolerated3.3729201.0-34.02231.113.20.00.0-0.10.0XPotentially BenignIn the WT, the phenyl ring of the Phe420 side chain, located on an α helix (res. Met414-Glu436), packs against hydrophobic residues in the interhelix area of the GAP domain (e.g., Leu689, Leu714, Leu717, Leu718). In the variant simulations, the iso-butyl side chain of Leu420 also packs into the hydrophobic inter-helix niche, but due to its smaller size, the resulting steric interactions are not as favorable as with phenylalanine. In short, the residue swap does not cause severe effects on the protein structure based on the variant simulations.
c.303C>AH101QLikely BenignUncertain 16-33432168-C-A16.20e-7-2.827Likely Benign0.124Likely BenignLikely Benign0.147Likely Benign-0.37Neutral0.824Possibly Damaging0.880Possibly Damaging4.24Benign0.00Affected4.32130-0.3-9.01
c.611C>GS204C
(3D Viewer)
Likely BenignPHUncertain 1-6.613Likely Benign0.127Likely BenignLikely Benign0.148Likely Benign0.65Ambiguous0.4-1.13Ambiguous-0.24Likely Benign0.10Likely Benign-0.64Neutral0.978Probably Damaging0.753Possibly Damaging4.13Benign0.05Affected3.44100-13.316.06223.6-13.80.60.30.00.2XUncertainThe hydroxyl-containing Ser204, located in the N-terminal loop before the first anti-parallel β sheet strand (res. Ile205-Pro208), is replaced by the thiol-containing cysteine. In the WT simulations, Ser204 simultaneously forms hydrogen bonds with the backbone carbonyl of Asp201 and the hydroxyl group of Thr224, helping to stabilize the two anti-parallel β strands (res. Ile205-Lys207 and Cys219-Thr223) at the end of the β sheet. Since the thiol group of cysteine forms weaker hydrogen bonds than the hydroxyl group of serine, Cys204 does not maintain the hydrogen bond network as stably as Ser204 in the variant simulations. However, because the model ends abruptly at the N-terminus, no definite conclusions can be drawn from the simulations.
c.3821G>AR1274HLikely Benign 16-33447869-G-A42.58e-6-5.259Likely Benign0.256Likely BenignLikely Benign0.149Likely Benign-3.20Deleterious1.000Probably Damaging0.995Probably Damaging2.49Pathogenic0.01Affected3.775021.3-19.05
c.2809G>CD937HLikely BenignUncertain 1-0.733Likely Benign0.677Likely PathogenicLikely Benign0.150Likely Benign-1.74Neutral1.000Probably Damaging0.975Probably Damaging2.68Benign0.13Tolerated3.775-110.322.05
c.484C>TR162CPathogenic 2-8.157Likely Pathogenic0.787Likely PathogenicAmbiguous0.150Likely Benign-2.05Neutral0.988Probably Damaging0.513Possibly Damaging4.00Benign0.11Tolerated3.744-4-37.0-53.05
c.901G>AA301T
(3D Viewer)
Likely BenignC2Uncertain 56-33437806-G-A21.24e-6-3.448Likely Benign0.070Likely BenignLikely Benign0.150Likely Benign0.36Likely Benign0.2-0.33Likely Benign0.02Likely Benign0.03Likely Benign-0.25Neutral0.997Probably Damaging0.989Probably Damaging4.15Benign0.22Tolerated4.321410-2.530.03219.8-42.8-0.10.0-0.50.2UncertainThe methyl group of Ala301, located in a β hairpin loop linking two anti-parallel β sheet strands (res. Met289-Pro298, res. Thr305-Asn315), points outward from the β hairpin loop, and its backbone atoms do not participate in the loop formation in the WT simulations. In the variant simulations, the hydroxyl group of the Thr301 side chain also mostly points outward; however, the guanidinium group of Arg299 is moved away from its central hairpin loop position.β hairpins are potential nucleation sites during the initial stages of protein folding, so even minor changes in them could be significant. Due to its location near the membrane surface, the residue swap could also affect the C2 loop dynamics and SynGAP-membrane association. However, this is beyond the scope of the solvent-only simulations to unravel.
c.865A>GM289V
(3D Viewer)
Likely BenignC2Benign 1-4.239Likely Benign0.117Likely BenignLikely Benign0.150Likely Benign1.09Ambiguous0.1-0.27Likely Benign0.41Likely Benign0.24Likely Benign-0.36Neutral0.136Benign0.054Benign1.80Pathogenic1.00Tolerated3.3823212.3-32.06204.251.00.00.00.20.0XPotentially BenignThe hydrophobic residue Met289, located in a β hairpin linking two anti-parallel β sheet strands (res. Met289-Arg299, res. Arg272-Leu286), is swapped for another hydrophobic residue, valine. In the variant simulations, the branched hydrocarbon side chain of Val289 packs against the phenol group of the Tyr291 side chain but is unable to form methionine-aromatic interactions. β hairpins are potential nucleation sites during the initial stages of protein folding, so even minor changes in them could be significant. However, based on the simulations, the residue swap does not cause adverse effects on the structure.
c.3326T>CL1109PLikely BenignConflicting 2-5.313Likely Benign0.120Likely BenignLikely Benign0.151Likely Benign-0.52Neutral0.002Benign0.003Benign2.65Benign0.07Tolerated4.322-3-3-5.4-16.04
c.2650C>TR884WLikely BenignUncertain 16-33443202-C-T53.10e-6-3.785Likely Benign0.332Likely BenignLikely Benign0.151Likely Benign0.26Neutral0.995Probably Damaging0.812Possibly Damaging2.56Benign0.05Affected4.324-323.630.03
c.2246G>AR749QLikely BenignLikely Benign 16-33441711-G-A42.48e-6-3.069Likely Benign0.212Likely BenignLikely Benign0.152Likely Benign-1.00Neutral0.999Probably Damaging0.994Probably Damaging2.64Benign0.03Affected4.322111.0-28.06
c.583G>CA195PLikely PathogenicLikely Pathogenic 1-9.715Likely Pathogenic0.978Likely PathogenicLikely Pathogenic0.152Likely Benign-3.03Deleterious0.997Probably Damaging0.916Probably Damaging4.00Benign0.04Affected3.5461-1-3.426.04
c.2405G>AG802DLikely BenignSH3-binding motifUncertain 16-33442957-G-A16.20e-7-5.083Likely Benign0.476AmbiguousLikely Benign0.153Likely Benign-0.38Neutral0.126Benign0.138Benign2.72Benign0.09Tolerated3.7751-1-3.158.04
c.2029A>TS677C
(3D Viewer)
Likely BenignGAPBenign 1-8.496Likely Pathogenic0.076Likely BenignLikely Benign0.153Likely Benign-0.51Ambiguous0.3-0.30Likely Benign-0.41Likely Benign0.15Likely Benign-2.41Neutral0.932Possibly Damaging0.222Benign3.25Benign0.04Affected3.4123-103.316.06
c.2210A>CQ737PLikely BenignUncertain 1-2.407Likely Benign0.054Likely BenignLikely Benign0.154Likely Benign-1.22Neutral0.005Benign0.013Benign2.78Benign0.04Affected4.073-101.9-31.01
c.3731G>AS1244NLikely PathogenicCoiled-coilUncertain 1-9.008Likely Pathogenic0.751Likely PathogenicLikely Benign0.154Likely Benign-1.87Neutral0.997Probably Damaging0.992Probably Damaging2.10Pathogenic0.15Tolerated3.77511-2.727.03
c.3907G>AG1303SLikely BenignUncertain 1-2.271Likely Benign0.125Likely BenignLikely Benign0.155Likely Benign-0.19Neutral0.649Possibly Damaging0.433Benign2.84Benign0.18Tolerated10-0.430.03
c.986G>AR329H
(3D Viewer)
Likely PathogenicC2Uncertain 16-33437891-G-A21.24e-6-10.154Likely Pathogenic0.769Likely PathogenicLikely Benign0.155Likely Benign2.53Destabilizing0.70.71Ambiguous1.62Ambiguous0.82Ambiguous-3.17Deleterious0.995Probably Damaging0.778Possibly Damaging4.04Benign0.05Affected3.4115201.3-19.05220.481.40.10.10.20.3UncertainThe guanidinium group of Arg329, located at the end of an anti-parallel β sheet strand (res. Ala322-Asp330), faces the negatively charged lipid bilayer surface. While the residue swap does not cause any apparent negative effects on the protein structure in the variant simulations, it could adversely affect the SynGAP-membrane association in reality. The positively charged Arg329 side chain forms hydrogen bonds with other loop residues (e.g., Ser371, Asp338) that are expected to dynamically interact with the membrane head group region. However, this phenomenon is beyond the scope of the solvent-only simulations to unravel. Notably, histidine can also be double protonated and positively charged, but this alternative protonation state was not considered in the variant simulations.
c.2840G>CG947ALikely BenignLikely Benign 16-33443392-G-C281.73e-5-6.511Likely Benign0.080Likely BenignLikely Benign0.156Likely Benign-0.41Neutral0.224Benign0.131Benign4.97Benign0.10Tolerated4.324102.214.03
c.1286G>AR429Q
(3D Viewer)
Likely BenignGAPUncertain 26-33438191-G-A106.20e-6-8.227Likely Pathogenic0.143Likely BenignLikely Benign0.156Likely Benign0.45Likely Benign0.10.36Likely Benign0.41Likely Benign0.98Ambiguous-1.25Neutral1.000Probably Damaging0.979Probably Damaging3.47Benign0.58Tolerated3.3825111.0-28.06235.859.50.00.0-0.30.4XPotentially PathogenicThe guanidinium group of the Arg429 side chain, located in an α helix (res. Met414-Glu436), either forms a salt bridge with the carboxylate group of an acidic residue (Asp474, Asp467) or an H-bond with the hydroxyl group of Ser471 in an opposing α helix (res. Ala461-Phe476). In the variant simulations, Gln429 cannot form ionic interactions with the acidic residues; however, the carboxamide group can form multiple H-bonds. The H-bonding coordination of the Asn429 side chain varied between the replica simulations. In one simulation, three H-bonds were formed simultaneously with the Asp467 side chain, the backbone carbonyl group of Asn426, and the amide group of Met430 at the end of the same α helix. The residue swap could affect the tertiary structure assembly during folding due to weaker bond formation, but no large-scale negative effects were seen during the simulations.
c.3049T>CF1017LLikely BenignBenign 1-2.048Likely Benign0.934Likely PathogenicAmbiguous0.157Likely Benign-2.38Neutral0.798Possibly Damaging0.373Benign2.65Benign0.72Tolerated3.775021.0-34.02
c.2444G>AR815HSH3-binding motifLikely Benign 26-33442996-G-A241.49e-5-7.474In-Between0.553AmbiguousLikely Benign0.157Likely Benign-1.81Neutral1.000Probably Damaging0.998Probably Damaging2.61Benign0.02Affected4.324201.3-19.0510.1016/j.ajhg.2020.11.011
c.3233T>AV1078DLikely BenignUncertain 1-5.155Likely Benign0.979Likely PathogenicLikely Pathogenic0.158Likely Benign-1.45Neutral0.003Benign0.008Benign3.84Benign0.00Affected3.775-3-2-7.715.96
c.73C>TR25WLikely BenignUncertain 26-33423482-C-T63.72e-6-5.133Likely Benign0.549AmbiguousLikely Benign0.158Likely Benign-1.60Neutral0.994Probably Damaging0.919Probably Damaging3.92Benign0.00Affected4.321-323.630.03
c.172A>GM58VLikely BenignUncertain 1-2.211Likely Benign0.688Likely PathogenicLikely Benign0.160Likely Benign-0.71Neutral0.006Benign0.091Benign4.19Benign0.00Affected4.321122.3-32.06
c.3160G>AG1054SLikely BenignBenign 16-33443712-G-A321.99e-5-5.294Likely Benign0.075Likely BenignLikely Benign0.160Likely Benign0.21Neutral0.121Benign0.013Benign4.04Benign0.63Tolerated3.77510-0.430.03
c.458C>AT153NLikely BenignConflicting 3-0.739Likely Benign0.226Likely BenignLikely Benign0.161Likely Benign0.88Neutral0.888Possibly Damaging0.537Possibly Damaging4.23Benign0.81Tolerated3.61500-2.813.00
c.2434C>TP812SLikely BenignSH3-binding motifUncertain 16-33442986-C-T16.20e-7-5.689Likely Benign0.456AmbiguousLikely Benign0.162Likely Benign-0.62Neutral0.999Probably Damaging0.966Probably Damaging2.89Benign0.95Tolerated4.3241-10.8-10.04
c.3262A>GS1088GLikely BenignUncertain 1-5.034Likely Benign0.285Likely BenignLikely Benign0.163Likely Benign-1.83Neutral0.979Probably Damaging0.973Probably Damaging2.63Benign0.03Affected3.775010.4-30.03
c.3287A>CE1096ALikely BenignUncertain 1-4.504Likely Benign0.510AmbiguousLikely Benign0.164Likely Benign-1.37Neutral0.626Possibly Damaging0.184Benign2.77Benign0.16Tolerated3.775-105.3-58.04
c.3380G>CG1127ALikely BenignConflicting 46-33443932-G-C42.68e-6-5.949Likely Benign0.080Likely BenignLikely Benign0.164Likely Benign-0.43Neutral0.001Benign0.002Benign4.83Benign1.00Tolerated4.324102.214.03
c.603T>GD201E
(3D Viewer)
Likely BenignPHConflicting 26-33435245-T-G201.24e-5-2.640Likely Benign0.406AmbiguousLikely Benign0.165Likely Benign0.42Likely Benign0.21.99Ambiguous1.21Ambiguous0.23Likely Benign-0.69Neutral0.633Possibly Damaging0.108Benign4.30Benign1.00Tolerated3.469320.014.03258.7-24.80.90.1-0.30.2XUncertainAsp201, an acidic residue located in the N-terminal loop before the first anti-parallel β sheet strand (res. Ile205-Pro208), is replaced by another acidic residue, glutamate. The carboxylate groups of both Asp201 and Glu201 side chains form hydrogen bonds with the hydroxyl group of Ser221 in the simulations. Due to its shorter side chain, Asp201 can also hydrogen bond with the backbone amide groups of neighboring loop residues Ser204 and Asp203. However, since the model ends abruptly at the N-terminus, no definite conclusions can be drawn from the simulations.
c.603T>AD201E
(3D Viewer)
Likely BenignPHBenign 1-2.640Likely Benign0.406AmbiguousLikely Benign0.165Likely Benign0.42Likely Benign0.21.99Ambiguous1.21Ambiguous0.23Likely Benign-0.69Neutral0.633Possibly Damaging0.108Benign4.30Benign1.00Tolerated3.469320.014.03258.7-24.80.90.1-0.30.2XUncertainAsp201, an acidic residue located in the N-terminal loop before the first anti-parallel β sheet strand (res. Ile205-Pro208), is replaced by another acidic residue, glutamate. The carboxylate groups of both Asp201 and Glu201 side chains form hydrogen bonds with the hydroxyl group of Ser221 in the simulations. Due to its shorter side chain, Asp201 can also hydrogen bond with the backbone amide groups of neighboring loop residues Ser204 and Asp203. However, since the model ends abruptly at the N-terminus, no definite conclusions can be drawn from the simulations.
c.3354C>AS1118RLikely BenignUncertain 1-2.670Likely Benign0.553AmbiguousLikely Benign0.166Likely Benign-0.74Neutral0.034Benign0.023Benign5.17Benign0.05Affected4.322-10-3.769.11
c.3494C>TS1165LLikely BenignConflicting 2-2.984Likely Benign0.793Likely PathogenicAmbiguous0.166Likely Benign-2.01Neutral0.998Probably Damaging0.992Probably Damaging2.60Benign0.33Tolerated3.883-3-24.626.0810.1016/j.ajhg.2020.11.011
c.3405G>CK1135NLikely BenignUncertain 1-5.715Likely Benign0.960Likely PathogenicLikely Pathogenic0.166Likely Benign-0.97Neutral0.411Benign0.321Benign5.43Benign0.07Tolerated4.322100.4-14.07
c.3721C>AL1241MCoiled-coilUncertain 1-5.881Likely Benign0.782Likely PathogenicLikely Benign0.167Likely Benign-1.43Neutral1.000Probably Damaging0.999Probably Damaging1.65Pathogenic0.00Affected42-1.918.03
c.485G>AR162HUncertain 16-33432782-G-A21.24e-6-9.730Likely Pathogenic0.480AmbiguousLikely Benign0.167Likely Benign-1.13Neutral0.957Probably Damaging0.513Possibly Damaging4.03Benign0.12Tolerated3.744201.3-19.05
c.2854G>AG952SLikely BenignConflicting 26-33443406-G-A21.24e-6-6.190Likely Benign0.077Likely BenignLikely Benign0.167Likely Benign0.19Neutral0.000Benign0.002Benign3.31Benign0.07Tolerated3.77510-0.430.03
c.2324G>CR775PLikely BenignBenign 1-5.072Likely Benign0.452AmbiguousLikely Benign0.168Likely Benign-0.79Neutral0.971Probably Damaging0.944Probably Damaging4.13Benign0.07Tolerated3.646-202.9-59.07
c.3055C>TR1019CLikely PathogenicConflicting 26-33443607-C-T106.19e-6-7.386In-Between0.646Likely PathogenicLikely Benign0.168Likely Benign-4.00Deleterious0.999Probably Damaging0.880Possibly Damaging2.36Pathogenic0.00Affected3.775-4-37.0-53.0510.1016/j.ajhg.2020.11.011
c.13C>GR5GLikely BenignUncertain 1-3.639Likely Benign0.150Likely BenignLikely Benign0.169Likely Benign-0.16Neutral0.013Benign0.003Benign4.12Benign0.00Affected4.321-2-34.1-99.14
c.311G>TR104LLikely BenignBenign 16-33432176-G-T16.20e-7-3.563Likely Benign0.578Likely PathogenicLikely Benign0.170Likely Benign-1.38Neutral0.001Benign0.002Benign4.05Benign0.00Affected4.321-2-38.3-43.03
c.3820C>TR1274CUncertain 16-33447868-C-T-6.467Likely Benign0.439AmbiguousLikely Benign0.170Likely Benign-5.22Deleterious1.000Probably Damaging0.996Probably Damaging2.46Pathogenic0.00Affected3.775-4-37.0-53.05
c.2131C>GL711V
(3D Viewer)
Likely PathogenicGAPUncertain16-33441596-C-G16.20e-7-10.045Likely Pathogenic0.709Likely PathogenicLikely Benign0.170Likely Benign3.48Destabilizing0.12.22Destabilizing2.85Destabilizing1.40Destabilizing-2.59Deleterious0.992Probably Damaging0.970Probably Damaging3.34Benign0.00Affected3.509120.4-14.03
c.3595G>AE1199KCoiled-coilUncertain 16-33446587-G-A16.20e-7-10.853Likely Pathogenic0.954Likely PathogenicAmbiguous0.171Likely Benign-2.26Neutral1.000Probably Damaging0.995Probably Damaging2.52Benign0.00Affected3.77501-0.4-0.94
c.3197C>TP1066LLikely BenignLikely Benign 16-33443749-C-T148.71e-6-5.478Likely Benign0.092Likely BenignLikely Benign0.173Likely Benign-3.68Deleterious0.996Probably Damaging0.903Possibly Damaging2.72Benign0.00Affected4.322-3-35.416.04
c.3308G>TR1103LLikely BenignUncertain 16-33443860-G-T-2.330Likely Benign0.205Likely BenignLikely Benign0.173Likely Benign-2.35Neutral0.002Benign0.005Benign2.44Pathogenic0.02Affected3.775-3-28.3-43.03
c.2245C>TR749WLikely Benign 16-33441710-C-T31.86e-6-7.647In-Between0.338Likely BenignLikely Benign0.173Likely Benign-2.62Deleterious1.000Probably Damaging0.998Probably Damaging2.59Benign0.00Affected4.3222-33.630.03
c.3661C>TR1221WLikely PathogenicCoiled-coilConflicting 36-33446653-C-T16.20e-7-10.938Likely Pathogenic0.651Likely PathogenicLikely Benign0.174Likely Benign-4.57Deleterious1.000Probably Damaging0.987Probably Damaging2.50Benign0.01Affected3.7752-33.630.03
c.2443C>TR815CLikely PathogenicSH3-binding motifUncertain 16-33442995-C-T53.10e-6-9.373Likely Pathogenic0.828Likely PathogenicAmbiguous0.174Likely Benign-3.89Deleterious1.000Probably Damaging0.998Probably Damaging2.59Benign0.00Affected4.324-4-37.0-53.05
c.2560C>TR854CLikely BenignUncertain 16-33443112-C-T31.86e-6-5.082Likely Benign0.170Likely BenignLikely Benign0.174Likely Benign-2.48Neutral1.000Probably Damaging0.947Probably Damaging4.05Benign0.01Affected3.883-3-47.0-53.05
c.2444G>TR815LLikely PathogenicSH3-binding motifUncertain 1-8.546Likely Pathogenic0.865Likely PathogenicAmbiguous0.175Likely Benign-3.06Deleterious0.999Probably Damaging0.997Probably Damaging2.63Benign0.03Affected4.324-2-38.3-43.03
c.3557C>TS1186LCoiled-coilUncertain 16-33444592-C-T-4.829Likely Benign0.923Likely PathogenicAmbiguous0.177Likely Benign-2.58Deleterious0.998Probably Damaging0.992Probably Damaging2.65Benign0.04Affected3.824-3-24.626.08
c.1604G>CS535T
(3D Viewer)
Likely BenignGAPBenign 16-33438847-G-C148.67e-6-3.886Likely Benign0.069Likely BenignLikely Benign0.177Likely Benign0.45Likely Benign0.1-0.27Likely Benign0.09Likely Benign0.17Likely Benign-0.81Neutral0.000Benign0.001Benign-1.25Pathogenic0.25Tolerated3.3735110.114.03201.3-17.3-0.10.7-0.20.1XPotentially BenignSer535 is located near the terminal end of an α-helix (res. Ala533-Val560) close to the membrane interface. In the WT simulations, the hydroxyl side chain of Ser535 forms hydrogen bonds with nearby residues (e.g., His539, Glu538) without any specific interactions. These hydrogen bonds disrupt the structure of the terminal end of the α-helix (Ala533-Ser535), causing it to weaken or unfold during the WT simulations. In the variant simulations, Thr535, a hydrophilic residue with a hydroxyl group of almost the same size as Ser, interacts more frequently with the preceding loop residues (e.g., Thr532, Cys531) due to its longer side chain. Regardless, the residue swap is tolerated in the simulations with no negative effects. However, due to its location near the SynGAP-membrane interface, the effect of the residue swap cannot be fully addressed using the SynGAP solvent-only simulations.10.1016/j.ajhg.2020.11.011
c.3835G>AA1279TLikely BenignUncertain 26-33447883-G-A21.29e-6-4.871Likely Benign0.071Likely BenignLikely Benign0.178Likely Benign-0.30Neutral0.001Benign0.000Benign2.71Benign0.09Tolerated3.77510-2.530.03
c.1339G>CV447L
(3D Viewer)
Likely BenignGAPUncertain 1-5.136Likely Benign0.491AmbiguousLikely Benign0.180Likely Benign-1.13Ambiguous0.10.54Ambiguous-0.30Likely Benign0.03Likely Benign-0.29Neutral0.947Possibly Damaging0.851Possibly Damaging3.61Benign0.90Tolerated3.373212-0.414.03
c.3397A>GI1133VLikely BenignBenign 16-33443949-A-G221.48e-5-3.362Likely Benign0.067Likely BenignLikely Benign0.180Likely Benign0.06Neutral0.007Benign0.007Benign5.47Benign0.58Tolerated4.32343-0.3-14.0310.1016/j.ajhg.2020.11.011
c.2681G>AG894ELikely BenignUncertain 16-33443233-G-A63.72e-6-5.377Likely Benign0.859Likely PathogenicAmbiguous0.180Likely Benign-2.07Neutral1.000Probably Damaging1.000Probably Damaging2.68Benign0.01Affected4.3240-2-3.172.06
c.1428C>GF476L
(3D Viewer)
GAPUncertain 26-33438460-C-G42.48e-6-10.109Likely Pathogenic0.994Likely PathogenicLikely Pathogenic0.180Likely Benign1.00Ambiguous0.11.04Ambiguous1.02Ambiguous0.75Ambiguous-1.10Neutral0.997Probably Damaging0.978Probably Damaging3.53Benign0.60Tolerated3.4022201.0-34.02235.916.10.00.1-0.20.0XPotentially BenignIn the WT simulations, the phenyl ring of Phe476, located at the end of an α-helix (res. Ala461-Phe476), packs with the hydrophobic side chains of Leu482 and Ile483. Additionally, Phe476 stacks with the Arg475 side chain on the preceding α-α loop connecting the two α-helices (res. Ala461-Phe476 and res. Leu489-Glu519) near the GAP-Ras interface.In the variant simulations, Leu476 can maintain hydrophobic packing with neighboring residues, although not as efficiently as the phenylalanine in the WT system. The absence of Phe476/Arg475 stacking weakens the integrity of the α-helix end in the variant simulations. Nonetheless, no large-scale adverse effects are observed in the simulations. Lastly, the potential effect of the residue swap on SynGAP-Ras complex formation or GTPase activation cannot be fully addressed using the SynGAP solvent-only simulations.
c.2218C>TR740WUncertain 26-33441683-C-T63.72e-6-8.561Likely Pathogenic0.168Likely BenignLikely Benign0.180Likely Benign-3.09Deleterious1.000Probably Damaging0.938Probably Damaging2.52Benign0.01Affected4.3222-33.630.03
c.455G>AR152QUncertain 16-33432752-G-A53.14e-6-10.336Likely Pathogenic0.989Likely PathogenicLikely Pathogenic0.181Likely Benign-2.34Neutral0.997Probably Damaging0.968Probably Damaging3.89Benign0.00Affected3.615111.0-28.06
c.2561G>AR854HLikely BenignUncertain 16-33443113-G-A42.48e-6-3.686Likely Benign0.094Likely BenignLikely Benign0.183Likely Benign-1.38Neutral0.997Probably Damaging0.899Possibly Damaging4.07Benign0.04Affected3.883201.3-19.05
c.2115G>CK705N
(3D Viewer)
Likely PathogenicGAPLikely Pathogenic 1-9.767Likely Pathogenic0.925Likely PathogenicAmbiguous0.183Likely Benign0.74Ambiguous0.00.37Likely Benign0.56Ambiguous0.44Likely Benign-3.12Deleterious0.996Probably Damaging0.876Possibly Damaging3.37Benign0.02Affected3.4710100.4-14.07221.4-20.20.00.00.00.1XUncertainThe amino side chain of Lys705, located at the end and outer surface of an α-helix (res. Thr704-Gly712), does not form any interactions in the WT simulations. In the variant simulations, the carboxamide side chain of Asn705 briefly forms a salt bridge with Glu706. However, there is no apparent difference between the systems. Due to the model ending abruptly at the C-terminus, no definite conclusions can be drawn based on the simulations.
c.2522T>CV841AUncertain 16-33443074-T-C31.86e-6-8.152Likely Pathogenic0.901Likely PathogenicAmbiguous0.183Likely Benign-2.13Neutral0.992Probably Damaging0.989Probably Damaging2.57Benign0.02Affected3.77500-2.4-28.05
c.323A>GK108RLikely BenignUncertain 16-33432188-A-G63.72e-6-2.892Likely Benign0.148Likely BenignLikely Benign0.184Likely Benign0.37Neutral0.993Probably Damaging0.956Probably Damaging4.22Benign1.00Tolerated3.61532-0.628.01
c.491G>AR164QUncertain 16-33432788-G-A21.24e-6-11.208Likely Pathogenic0.600Likely PathogenicLikely Benign0.184Likely Benign-1.86Neutral0.957Probably Damaging0.342Benign3.82Benign0.00Affected3.744111.0-28.06
c.3862A>GK1288EUncertain 16-33447910-A-G53.22e-6-2.751Likely Benign0.407AmbiguousLikely Benign0.185Likely Benign-3.27Deleterious0.979Probably Damaging0.973Probably Damaging2.13Pathogenic0.00Affected3.775100.40.94
c.2852A>GH951RLikely BenignLikely Pathogenic 1-4.964Likely Benign0.125Likely BenignLikely Benign0.185Likely Benign-1.08Neutral0.048Benign0.029Benign5.46Benign0.24Tolerated3.77520-1.319.05
c.2741A>TD914VLikely BenignUncertain 1-4.260Likely Benign0.723Likely PathogenicLikely Benign0.187Likely Benign-2.24Neutral0.999Probably Damaging0.986Probably Damaging2.64Benign0.01Affected3.775-3-27.7-15.96
c.3364G>AG1122SLikely BenignBenign/Likely benign 26-33443916-G-A271.79e-5-4.880Likely Benign0.072Likely BenignLikely Benign0.189Likely Benign-0.08Neutral0.022Benign0.006Benign4.89Benign0.92Tolerated3.77510-0.430.03
c.892C>TP298S
(3D Viewer)
Likely BenignC2Benign 16-33437797-C-T53.10e-6-6.342Likely Benign0.144Likely BenignLikely Benign0.189Likely Benign1.38Ambiguous0.21.41Ambiguous1.40Ambiguous0.58Ambiguous-1.20Neutral0.991Probably Damaging0.898Possibly Damaging2.03Pathogenic0.85Tolerated3.3920-110.8-10.04
c.76G>AG26RLikely BenignBenign 16-33423485-G-A31.86e-6-2.946Likely Benign0.678Likely PathogenicLikely Benign0.189Likely Benign-2.22Neutral0.994Probably Damaging0.990Probably Damaging3.87Benign0.00Affected4.321-3-2-4.199.14
c.484C>GR162GLikely BenignUncertain 1-6.985Likely Benign0.664Likely PathogenicLikely Benign0.190Likely Benign-0.73Neutral0.487Possibly Damaging0.272Benign4.09Benign0.78Tolerated3.744-2-34.1-99.14
c.407G>AR136QBenign 16-33432704-G-A139.17e-6-11.146Likely Pathogenic0.950Likely PathogenicAmbiguous0.190Likely Benign-2.26Neutral0.957Probably Damaging0.342Benign3.52Benign0.01Affected3.615111.0-28.06
c.2206C>TR736CConflicting 36-33441671-C-T84.96e-6-7.113In-Between0.120Likely BenignLikely Benign0.190Likely Benign-2.06Neutral0.999Probably Damaging0.825Possibly Damaging2.48Pathogenic0.00Affected4.073-4-37.0-53.05
c.2669G>CR890PLikely BenignLikely Benign 26-33443221-G-C281.74e-5-1.931Likely Benign0.301Likely BenignLikely Benign0.191Likely Benign-1.21Neutral0.999Probably Damaging0.977Probably Damaging4.02Benign0.28Tolerated4.3240-22.9-59.07
c.2282G>AR761QLikely BenignUncertain 16-33441747-G-A116.81e-6-4.187Likely Benign0.202Likely BenignLikely Benign0.191Likely Benign-0.63Neutral0.996Probably Damaging0.878Possibly Damaging2.75Benign0.40Tolerated3.995111.0-28.06
c.1042G>AV348M
(3D Viewer)
C2Uncertain 1-7.076In-Between0.546AmbiguousLikely Benign0.191Likely Benign-1.19Ambiguous0.10.72Ambiguous-0.24Likely Benign0.76Ambiguous-1.62Neutral0.966Probably Damaging0.564Possibly Damaging1.58Pathogenic0.03Affected3.372521-2.332.06253.8-47.4-0.30.10.20.1XPotentially BenignThe iso-propyl side chain of Val348, located in an anti-parallel β sheet strand (res. Gly341-Pro349), packs against multiple hydrophobic C2 domain residues (e.g., Leu353, Leu323, Leu402). In the variant simulations, the thioether side chain of Met348 can form similar interactions as valine due to its comparable hydrophobic profile. In fact, the thioether group of methionine can even stack favorably with the phenol ring of Tyr363 in the anti-parallel β sheet strand (res. Ala399-Ile411). Overall, the residue swap does not appear to cause negative effects on the protein structure based on the simulations.
c.1436G>AR479Q
(3D Viewer)
Likely BenignGAPUncertain 16-33438468-G-A74.34e-6-7.109In-Between0.259Likely BenignLikely Benign0.191Likely Benign0.54Ambiguous0.10.57Ambiguous0.56Ambiguous0.49Likely Benign-1.16Neutral1.000Probably Damaging0.991Probably Damaging3.42Benign0.31Tolerated3.3932111.0-28.06
c.2525C>AS842YLikely PathogenicLikely Pathogenic 1-16.124Likely Pathogenic0.995Likely PathogenicLikely Pathogenic0.191Likely Benign-4.28Deleterious0.944Possibly Damaging0.676Possibly Damaging1.97Pathogenic0.00Affected3.775-3-2-0.576.10
c.3920C>AP1307QLikely BenignUncertain 16-33451794-C-A-4.227Likely Benign0.114Likely BenignLikely Benign0.192Likely Benign-0.88Neutral0.988Probably Damaging0.765Possibly Damaging2.82Benign0.03Affected3.7750-1-1.931.01
c.2714G>AR905HLikely BenignUncertain 16-33443266-G-A84.96e-6-4.182Likely Benign0.457AmbiguousLikely Benign0.192Likely Benign-1.11Neutral1.000Probably Damaging0.991Probably Damaging2.59Benign0.09Tolerated3.775201.3-19.05
c.1300G>AV434I
(3D Viewer)
Likely BenignGAPUncertain 16-33438205-G-A16.19e-7-6.999Likely Benign0.129Likely BenignLikely Benign0.192Likely Benign-0.04Likely Benign0.00.22Likely Benign0.09Likely Benign0.31Likely Benign-0.82Neutral0.947Possibly Damaging0.851Possibly Damaging3.53Benign0.18Tolerated3.3729430.314.03246.7-27.70.00.00.10.0XPotentially BenignThe iso-propyl side chain of Val434, located at the end of an α helix (res. Met414-Glu436), packs against hydrophobic residues in an interhelix space (e.g., Met430, Ala707, Leu711). In the variant simulations, the sec-butyl group of Ile434 is able to form the same hydrophobic interactions. Accordingly, the residue swap does not negatively affect the protein structure based on the simulations.
c.2619C>GS873RUncertain 16-33443171-C-G16.20e-7-5.856Likely Benign0.976Likely PathogenicLikely Pathogenic0.192Likely Benign-2.74Deleterious0.997Probably Damaging0.995Probably Damaging2.67Benign0.06Tolerated3.7750-1-3.769.11
c.3116T>CI1039TLikely BenignUncertain 16-33443668-T-C127.43e-6-2.465Likely Benign0.645Likely PathogenicLikely Benign0.193Likely Benign0.45Neutral0.004Benign0.008Benign2.75Benign0.10Tolerated3.775-10-5.2-12.05
c.2548G>AG850RLikely BenignUncertain 1-5.082Likely Benign0.398AmbiguousLikely Benign0.194Likely Benign-0.07Neutral0.010Benign0.010Benign4.30Benign0.01Affected3.775-3-2-4.199.14
c.1976C>TS659F
(3D Viewer)
Likely PathogenicGAPUncertain 1-10.925Likely Pathogenic0.662Likely PathogenicLikely Benign0.194Likely Benign-0.81Ambiguous0.1-0.25Likely Benign-0.53Ambiguous0.32Likely Benign-4.59Deleterious0.806Possibly Damaging0.171Benign3.39Benign0.05Affected3.3828-3-23.660.10221.3-61.20.00.00.60.4XPotentially BenignIn the WT simulations, the hydroxyl group of Ser659, located in a kink in the middle of the long α-helix (res. Ser641-Glu666), forms a hydrogen bond with the carboxylate group of Glu656. However, the phenol ring of the Phe659 side chain cannot form a similar hydrogen bond. Instead, it interacts with the hydrophobic isopropyl side chain of Val555 from the opposing α-helix (res. Ala533-Val560). This residue swap may therefore cause issues during protein folding.
c.2713C>TR905CConflicting 26-33443265-C-T159.31e-6-5.578Likely Benign0.723Likely PathogenicLikely Benign0.194Likely Benign-3.14Deleterious1.000Probably Damaging0.980Probably Damaging2.57Benign0.01Affected3.775-4-37.0-53.05
c.2485G>AE829KLikely PathogenicPathogenic 1-7.527In-Between0.807Likely PathogenicAmbiguous0.194Likely Benign-2.65Deleterious0.994Probably Damaging0.900Possibly Damaging2.27Pathogenic0.00Affected3.77501-0.4-0.94
c.2255C>TS752LLikely BenignUncertain 26-33441720-C-T63.72e-6-3.386Likely Benign0.182Likely BenignLikely Benign0.195Likely Benign-2.09Neutral0.993Probably Damaging0.641Possibly Damaging1.51Pathogenic0.01Affected3.995-3-24.626.08
c.2945A>GY982CLikely BenignLikely Benign 16-33443497-A-G21.24e-6-6.256Likely Benign0.746Likely PathogenicLikely Benign0.195Likely Benign-1.67Neutral0.997Probably Damaging0.923Probably Damaging3.87Benign0.00Affected4.3210-23.8-60.04
c.1998G>CE666D
(3D Viewer)
Likely PathogenicGAPUncertain 1-8.820Likely Pathogenic0.704Likely PathogenicLikely Benign0.197Likely Benign0.88Ambiguous0.00.37Likely Benign0.63Ambiguous1.05Destabilizing-2.69Deleterious0.992Probably Damaging0.603Possibly Damaging3.43Benign0.06Tolerated3.3828320.0-14.03237.216.50.00.0-0.30.1XPotentially PathogenicThe carboxylate group of Glu666, located on the α-helix (res. Ser641-Glu666), is involved in a highly coordinated hydrogen-bonding network between residues from two α-helices (res. Ser641-Glu666 and res. Arg563-Glu578) and from the α-α loop connecting the two α-helices (res. Ser641-Glu666 and res. Leu685-Val699), such as Lys566, Thr672, and Asn669, in the WT simulations. In the variant simulations, the shorter side chain of Asp666 cannot maintain these interactions as efficiently as Glu666 in the WT, resulting in a less coordinated hydrogen-bond network.
c.86T>CM29TLikely BenignUncertain 1-2.167Likely Benign0.122Likely BenignLikely Benign0.199Likely Benign-0.37Neutral0.018Benign0.184Benign4.33Benign0.00Affected4.321-1-1-2.6-30.09
c.2668C>TR890CBenign 16-33443220-C-T95.58e-6-5.786Likely Benign0.402AmbiguousLikely Benign0.200Likely Benign-3.38Deleterious1.000Probably Damaging0.971Probably Damaging3.94Benign0.04Affected4.324-4-37.0-53.05
c.2282G>CR761PLikely BenignUncertain 36-33441747-G-C16.20e-7-5.091Likely Benign0.640Likely PathogenicLikely Benign0.201Likely Benign-1.89Neutral0.999Probably Damaging0.968Probably Damaging2.69Benign0.38Tolerated3.9950-22.9-59.07
c.1594A>CT532P
(3D Viewer)
Likely BenignGAPBenign 1-2.143Likely Benign0.061Likely BenignLikely Benign0.201Likely Benign-0.30Likely Benign0.20.06Likely Benign-0.12Likely Benign0.08Likely Benign-0.90Neutral0.005Benign0.008Benign-1.28Pathogenic0.18Tolerated3.37350-1-0.9-3.99174.235.10.40.00.10.0XPotentially BenignThr532 is located on an α-α loop between the two α-helices (res. Gly502-Tyr518 and Ala533-Val560) facing the membrane. In the WT simulations, the hydroxyl group of Thr532 occasionally forms hydrogen bonds with the backbone atoms of other loop residues without any specific interaction. In the variant simulations, the Pro532 residue swap does not cause structural changes. Although hydrophilic residues seem more favorable in the loop, the pyrrolidine side chain of proline is well suited for unstructured protein regions such as loops. However, due to its location at the SynGAP-membrane interface, the effect of the residue swap cannot be fully addressed using the SynGAP solvent-only simulations.
c.3511G>AA1171TLikely BenignCoiled-coilUncertain 1-3.658Likely Benign0.149Likely BenignLikely Benign0.201Likely Benign-0.48Neutral0.245Benign0.138Benign5.45Benign0.07Tolerated4.32410-2.530.03
c.3253C>TR1085WUncertain 16-33443805-C-T21.26e-6-6.339Likely Benign0.821Likely PathogenicAmbiguous0.202Likely Benign-3.15Deleterious1.000Probably Damaging0.996Probably Damaging2.70Benign0.00Affected3.775-323.630.03
c.1600T>CS534P
(3D Viewer)
Likely BenignGAPUncertain 16-33438843-T-C31.86e-6-5.056Likely Benign0.265Likely BenignLikely Benign0.203Likely Benign-0.40Likely Benign0.20.35Likely Benign-0.03Likely Benign0.47Likely Benign-3.81Deleterious0.993Probably Damaging0.993Probably Damaging3.32Benign0.05Affected3.3735-11-0.810.04

Found 757 rows. Show 200 rows per page. Page 2/4 |